Ftse Mib
35.143,06
-0,49%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.731,05
2,51%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tempus AI Inc (TEM) Tempus AI Inc (TEM) Notizie

TEM

Tempus AI (TEM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TEM
DataOraFonteTitoloSimboloCompagnia
08/01/202522:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TEMTempus AI Inc
08/01/202517:58Business WireTempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker AlgorithmsNASDAQ:TEMTempus AI Inc
07/01/202514:30Business WireTempus to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TEMTempus AI Inc
03/01/202501:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TEMTempus AI Inc
18/12/202414:30Business WireTempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare SolutionsNASDAQ:TEMTempus AI Inc
17/12/202414:30Business WireNew CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF DeviceNASDAQ:TEMTempus AI Inc
16/12/202414:00Business WirePersonalis and Tempus Expand Collaboration to BiopharmaNASDAQ:TEMTempus AI Inc
25/11/202414:30Business WireTempus to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:TEMTempus AI Inc
12/11/202422:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TEMTempus AI Inc
12/11/202414:30Business WireTempus Molecular Profiling Integration Now Available Through Flatiron’s OncoEMR®NASDAQ:TEMTempus AI Inc
11/11/202414:30Business WireTempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer CareNASDAQ:TEMTempus AI Inc
08/11/202414:30Business WireTempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual MeetingNASDAQ:TEMTempus AI Inc
07/11/202422:30Business WireTempus Announces the Clinical Launch of its Immune Profile Score Algorithmic TestNASDAQ:TEMTempus AI Inc
05/11/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TEMTempus AI Inc
04/11/202422:01Business WireTempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry GeneticsNASDAQ:TEMTempus AI Inc
04/11/202402:06Business WireTempus to Report Third Quarter 2024 Financial Results on November 4NASDAQ:TEMTempus AI Inc
24/10/202414:30Business WireTempus to Report Third Quarter 2024 Financial Results on November 7NASDAQ:TEMTempus AI Inc
26/09/202414:30Business WireTempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and DevelopmentNASDAQ:TEMTempus AI Inc
12/09/202414:30Business WireTempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for PatientsNASDAQ:TEMTempus AI Inc
04/09/202414:30Business WireTempus Announces Real World Data Collaboration with BioNTechNASDAQ:TEMTempus AI Inc
28/08/202414:30Business WireTempus to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:TEMTempus AI Inc
08/08/202414:30Business WireNPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational AssayNASDAQ:TEMTempus AI Inc
06/08/202422:01Business WireTempus Reports Second Quarter 2024 ResultsNASDAQ:TEMTempus AI Inc
01/08/202414:30Business WireTempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2NASDAQ:TEMTempus AI Inc
30/07/202414:30Business WireTempus Announces Expanded Data and Sequencing Collaboration with Remix TherapeuticsNASDAQ:TEMTempus AI Inc
17/07/202415:30Business WireTempus to Report Second Quarter 2024 Financial Results on August 6NASDAQ:TEMTempus AI Inc
16/07/202415:30Business WireTempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic TestsNASDAQ:TEMTempus AI Inc
10/07/202415:30Business WireTempus Surpasses 500 Research PublicationsNASDAQ:TEMTempus AI Inc
10/07/202412:42IH Market NewsMicrosoft and Apple Exit OpenAI Board, TSMC Exceeds Forecasts with Record Revenue, and Other Key UpdatesNASDAQ:TEMTempus AI Inc
08/07/202415:30Business WireAmerican Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSMNASDAQ:TEMTempus AI Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TEM

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network